Tested and proven solutions to the challenges of biological drug
product development Biological drug products play a central role in
combating human diseases; however, developing new successful
biological drugs presents many challenges, including labor intensive
production processes, tighter regulatory controls, and increased
market competition. This book reviews the current state of the
science, offering readers a single resource that sets forth the
fundamentals as well as tested and proven development strategies for
biological drugs. Moreover, the book prepares readers for the
challenges that typically arise during drug development, offering
straightforward solutions to improve their ability to pass through all
the regulatory hurdles and deliver new drug products to the market.
Biological Drug Products begins with general considerations for the
development of any biological drug product and then explores the
strategies and challenges involved in the development of specific
types of biologics. Divided into five parts, the book examines: Part
1: General Aspects Part 2: Proteins and Peptides Part 3: Vaccines Part
4: Novel Biologics Part 5: Product Administration/Delivery Each
chapter has been prepared by one or more leading experts in biological
drug development. Contributions are based on a comprehensive review
and analysis of the current literature as well as the authors'
first-hand experience developing and testing new drugs. References at
the end of each chapter serve as a gateway to original research papers
and reviews in the field. By incorporating lessons learned and future
directions for research, Biological Drug Products enables
pharmaceutical scientists and students to improve their success rate
in developing new biologics to treat a broad range of human diseases.
Les mer
Development and Strategies
Produktdetaljer
ISBN
9781118695227
Publisert
2014
Utgave
1. utgave
Utgiver
Vendor
Wiley-Blackwell
Språk
Product language
Engelsk
Format
Product format
Digital bok
Antall sider
744
Forfatter